Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice
Copyright © 2021 Elsevier Inc. All rights reserved..
Perturbations in the glutamate-glutamine cycle and glutamate release from presynaptic terminals have been involved in the development of cognitive deficits in Alzheimer's disease (AD) patients and mouse models. Glutamate transporter-1 (GLT-1) removes glutamate from the synaptic cleft and transports it into astrocytes, where it is used as substrate for the glutamate-glutamine cycle. Ceftriaxone has been reported to improve cognitive deficits in AD mice by increasing GLT-1 expression, glutamate transformation to glutamine, and glutamine efflux from astrocytes. However, the impact of ceftriaxone on glutamine metabolism in neurons is unknown. The present study aimed to investigate whether ceftriaxone regulated the production and vesicular assembly of glutamate in the presynaptic terminals of neurons and to determine GLT-1 involvement in this process. We used the amyloid precursor protein (APP)/presenilin-1 (PS1) AD mouse model and GLT-1 knockdown APP/PS1 (GLT-1+/-/APP/PS1) mice. The expression levels of sodium-coupled neutral amino-acid transporter 1 (SNAT1) and vesicular glutamate transporters 1 and 2 (VGLUT1/2) were analyzed by immunofluorescence and immunohistochemistry staining as well as by Western blotting. Glutaminase activity was assayed by fluorometry. Ceftriaxone treatment significantly increased SNAT1 expression and glutaminase activity in neurons in APP/PS1 mice. Similarly, VGLUT1/2 levels were increased in the presynaptic terminals of APP/PS1 mice treated with ceftriaxone. The deletion of one GLT-1 allele in APP/PS1 mice prevented the ceftriaxone-induced upregulation of SNAT1 and VGLUT1/2 expression, indicating that GLT-1 played an important role in ceftriaxone effect. Based on the role of SNAT1, glutaminase, and VGLUT1/2 in the glutamate-glutamine cycle in neurons, the present results suggested that ceftriaxone improved the production and vesicular assembly of glutamate as a neurotransmitter in presynaptic terminals by acting on GLT-1 in APP/PS1 mice.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:183 |
---|---|
Enthalten in: |
Neurobiology of learning and memory - 183(2021) vom: 01. Sept., Seite 107480 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fan, ShuJuan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 08.02.2022 Date Revised 08.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.nlm.2021.107480 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM327008660 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM327008660 | ||
003 | DE-627 | ||
005 | 20231225195826.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.nlm.2021.107480 |2 doi | |
028 | 5 | 2 | |a pubmed24n1089.xml |
035 | |a (DE-627)NLM327008660 | ||
035 | |a (NLM)34153453 | ||
035 | |a (PII)S1074-7427(21)00102-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fan, ShuJuan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.02.2022 | ||
500 | |a Date Revised 08.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
520 | |a Perturbations in the glutamate-glutamine cycle and glutamate release from presynaptic terminals have been involved in the development of cognitive deficits in Alzheimer's disease (AD) patients and mouse models. Glutamate transporter-1 (GLT-1) removes glutamate from the synaptic cleft and transports it into astrocytes, where it is used as substrate for the glutamate-glutamine cycle. Ceftriaxone has been reported to improve cognitive deficits in AD mice by increasing GLT-1 expression, glutamate transformation to glutamine, and glutamine efflux from astrocytes. However, the impact of ceftriaxone on glutamine metabolism in neurons is unknown. The present study aimed to investigate whether ceftriaxone regulated the production and vesicular assembly of glutamate in the presynaptic terminals of neurons and to determine GLT-1 involvement in this process. We used the amyloid precursor protein (APP)/presenilin-1 (PS1) AD mouse model and GLT-1 knockdown APP/PS1 (GLT-1+/-/APP/PS1) mice. The expression levels of sodium-coupled neutral amino-acid transporter 1 (SNAT1) and vesicular glutamate transporters 1 and 2 (VGLUT1/2) were analyzed by immunofluorescence and immunohistochemistry staining as well as by Western blotting. Glutaminase activity was assayed by fluorometry. Ceftriaxone treatment significantly increased SNAT1 expression and glutaminase activity in neurons in APP/PS1 mice. Similarly, VGLUT1/2 levels were increased in the presynaptic terminals of APP/PS1 mice treated with ceftriaxone. The deletion of one GLT-1 allele in APP/PS1 mice prevented the ceftriaxone-induced upregulation of SNAT1 and VGLUT1/2 expression, indicating that GLT-1 played an important role in ceftriaxone effect. Based on the role of SNAT1, glutaminase, and VGLUT1/2 in the glutamate-glutamine cycle in neurons, the present results suggested that ceftriaxone improved the production and vesicular assembly of glutamate as a neurotransmitter in presynaptic terminals by acting on GLT-1 in APP/PS1 mice | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a APP/PS1 mice | |
650 | 4 | |a Ceftriaxone | |
650 | 4 | |a GLT-1 | |
650 | 4 | |a Glutaminase | |
650 | 4 | |a SNAT1 | |
650 | 4 | |a VGLUT | |
650 | 7 | |a APP protein, human |2 NLM | |
650 | 7 | |a Amino Acid Transport System A |2 NLM | |
650 | 7 | |a Amyloid beta-Protein Precursor |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Excitatory Amino Acid Transporter 2 |2 NLM | |
650 | 7 | |a PSEN1 protein, human |2 NLM | |
650 | 7 | |a Presenilin-1 |2 NLM | |
650 | 7 | |a Slc17a6 protein, mouse |2 NLM | |
650 | 7 | |a Slc17a7 protein, mouse |2 NLM | |
650 | 7 | |a Slc1a2 protein, mouse |2 NLM | |
650 | 7 | |a Slc38a1 protein, mouse |2 NLM | |
650 | 7 | |a Vesicular Glutamate Transport Protein 1 |2 NLM | |
650 | 7 | |a Vesicular Glutamate Transport Protein 2 |2 NLM | |
650 | 7 | |a Glutamic Acid |2 NLM | |
650 | 7 | |a 3KX376GY7L |2 NLM | |
650 | 7 | |a Ceftriaxone |2 NLM | |
650 | 7 | |a 75J73V1629 |2 NLM | |
650 | 7 | |a Glutaminase |2 NLM | |
650 | 7 | |a EC 3.5.1.2 |2 NLM | |
700 | 1 | |a Li, Li |e verfasserin |4 aut | |
700 | 1 | |a Xian, XiaoHui |e verfasserin |4 aut | |
700 | 1 | |a Liu, LiRong |e verfasserin |4 aut | |
700 | 1 | |a Gao, JunXia |e verfasserin |4 aut | |
700 | 1 | |a Li, WenBin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neurobiology of learning and memory |d 1998 |g 183(2021) vom: 01. Sept., Seite 107480 |w (DE-627)NLM07521248X |x 1095-9564 |7 nnns |
773 | 1 | 8 | |g volume:183 |g year:2021 |g day:01 |g month:09 |g pages:107480 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nlm.2021.107480 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 183 |j 2021 |b 01 |c 09 |h 107480 |